Although immunotherapy has revolutionised cancer treatment, several challenges remain:
- Many patients do not respond to, or become resistant to, immunotherapy
- Some tumour types are non-responsive to immunotherapy (cold)
- Efficacy can be limited by safety and toxicity
There is scope to increase the efficacy, applicability, and/or safety of existing immunotherapies.